Patent update April 10, 2018

In the patent dispute between Osstell and Integration Diagnostics, the ruling has now become final and non-appealable.
Integration Diagnostics won this dispute on all points, and has thereby proven that the technology used by Penguin RFA does not infringe on the patented Osstell technology.
“Penguin RFA is a new development in the field of implant stability diagnostics and ISQ measurements, and gives clinicians access to easy-to-use, affordable measurements, that do not need disposables.” says Anders Petersson, inventor and CEO